查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1413091

奈米医学市场：按分子类型、形态、应用和适应症分类 - 全球预测 2024-2030

Nanomedicine Market by Molecule Type (Nanodevices, Nanoparticles, Nanoshells), Modality (Diagnostics, Treatment), Application, Indication - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

预计2023年奈米药物市场规模为2,062.5亿美元，预估2024年将达2,273.7亿美元，2030年将达4,258.8亿美元，复合年增长率为10.91%。

全球奈米医学市场

主要市场统计
基准年[2023] 2062.5亿美元
预测年份 [2024] 2273.7亿美元
预测年份 [2030] 4258.8亿美元
复合年增长率（%） 10.91%
奈米医学市场-IMG1

FPNV定位矩阵

FPNV定位矩阵对于评估奈米医学市场至关重要。我们检视与业务策略和产品满意度相关的关键指标，以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出资讯的决策。根据评估，供应商被分为四个成功程度不同的像限：前沿（F）、探路者（P）、利基（N）和重要（V）。

市场占有率分析

市场占有率分析是一种综合工具，可以对奈米医学市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献，以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外，该分析还提供了对该行业竞争特征的宝贵考察，包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。这种详细程度的提高使供应商能够做出更资讯的决策并制定有效的策略，从而在市场上获得竞争优势。

该报告对以下几个方面提供了宝贵的见解：

1-市场渗透率：提供有关主要企业所服务的市场的全面资讯。

2-市场开拓：我们深入研究利润丰厚的新兴市场，并分析它们在成熟细分市场中的渗透率。

3- 市场多元化：提供有关新产品发布、开拓地区、最新发展和投资的详细资讯。

4-竞争力评估与资讯：对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况、製造能力等进行全面评估。

5- 产品开发与创新：提供对未来技术、研发活动和突破性产品开发的见解。

本报告解决了以下关键问题：

1-奈米医学市场的市场规模和预测是多少？

2-奈米医学市场预测期内需要考虑投资的产品、细分市场、应用和领域有哪些？

3-奈米医学市场的技术趋势和法律规范是什么？

4-奈米医学市场主要厂商的市场占有率是多少？

5-进入奈米医药市场的合适型态和策略手段是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 慢性病的流行和有效治疗的需求
      • 利用奈米医学技术进行个人化医疗
      • 在体外诊断和体内成像的应用
    • 抑制因素
      • 奈米药物的开发和商业化成本高昂
    • 机会
      • 新型奈米药物开发策略联盟
      • 奈米医学研究和开发的有利资金形势
    • 任务
      • 可用的临床证据有限
  • 市场区隔分析
  • 市场趋势分析
  • 高通膨的累积效应
  • 波特五力分析
  • 价值炼和关键路径分析
  • 法律规范

第六章以分子类型分類的奈米医学市场

  • 奈米装置
  • 奈米粒子
    • 树状聚合物
    • 水凝胶奈米颗粒
    • 无机奈米粒子
    • 脂质体
    • 金属和金属氧化物奈米粒子
    • 聚合物和聚合物药物缀合物
  • 奈米壳
  • 奈米管

第七章 奈米医学市场：依形式

  • 诊断
  • 过程

第八章奈米医学市场：依应用分类

  • 诊断影像
  • 药物输送
  • 植入
  • 再生医学
  • 疫苗

第九章 奈米医学市场（按适应症）

  • 临床循环系统
  • 临床肿瘤学
  • 免疫学
  • 感染疾病
  • 神经病学
  • 眼科
  • 整形外科
  • 泌尿系统

第十章美洲奈米医学市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太地区奈米医学市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章欧洲、中东和非洲的奈米医学市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争形势

  • FPNV定位矩阵
  • 市场占有率分析：主要企业
  • 主要企业竞争情境分析

第14章竞争产品组合

  • 主要公司简介
    • AMAG Pharmaceuticals, Inc.
    • Amgen Inc.
    • Arrowhead Pharmaceuticals, Inc.
    • Bausch Health Companies Inc.
    • Bayer Healthcare
    • Biogen Inc.
    • Bristol-Myers Squibb Company
    • Celgene Corporation
    • Eisai Co Ltd
    • F. Hoffmann-La Roche AG
    • Galen Ltd
    • General Electric Company
    • Gilead Sciences, Inc.
    • Ipsen SA
    • Jazz Pharmaceuticals plc
    • Lantheus Holdings, Inc.
    • Leadient BioSciences Inc.
    • Mallinckrodt Pharmaceuticals
    • Merck & Co., Inc.
    • Nano spectra Biosciences, Inc.
    • Novo Nordisk A/S
    • OSARTIS GmbH
    • Pacira BioSciences Inc.
    • Pfizer Inc.
    • Sanofi SA
    • Taiwan Liposome Company, Ltd.
    • Takeda Pharmaceutical Company Limited
    • Teva Pharmaceuticals Ltd.
    • UCB SA
    • Zimmer Biomet Holdings, Inc.
  • 主要产品系列

第十五章附录

  • 讨论指南
  • 关于许可证和定价
Product Code: MRR-C002B1C9958A

[180 Pages Report] The Nanomedicine Market size was estimated at USD 206.25 billion in 2023 and expected to reach USD 227.37 billion in 2024, at a CAGR 10.91% to reach USD 425.88 billion by 2030.

Global Nanomedicine Market

KEY MARKET STATISTICS
Base Year [2023] USD 206.25 billion
Estimated Year [2024] USD 227.37 billion
Forecast Year [2030] USD 425.88 billion
CAGR (%) 10.91%
Nanomedicine Market - IMG1

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Nanomedicine Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Nanomedicine Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Nanomedicine Market, highlighting leading vendors and their innovative profiles. These include AMAG Pharmaceuticals, Inc., Amgen Inc., Arrowhead Pharmaceuticals, Inc., Bausch Health Companies Inc., Bayer Healthcare, Biogen Inc., Bristol-Myers Squibb Company, Celgene Corporation, Eisai Co Ltd, F. Hoffmann-La Roche AG, Galen Ltd, General Electric Company, Gilead Sciences, Inc., Ipsen SA, Jazz Pharmaceuticals plc, Lantheus Holdings, Inc., Leadient BioSciences Inc., Mallinckrodt Pharmaceuticals, Merck & Co., Inc., Nano spectra Biosciences, Inc., Novo Nordisk A/S, OSARTIS GmbH, Pacira BioSciences Inc., Pfizer Inc., Sanofi S.A., Taiwan Liposome Company, Ltd., Takeda Pharmaceutical Company Limited, Teva Pharmaceuticals Ltd., UCB SA, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Nanomedicine Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Molecule Type
    • Nanodevices
    • Nanoparticles
      • Dendrimers
      • Hydrogel Nanoparticles
      • Inorganic Nanoparticles
      • Liposomes
      • Metal & Metal Oxide Nanoparticles
      • Polymers & Polymer Drug Conjugates
    • Nanoshells
    • Nanotubes
  • Modality
    • Diagnostics
    • Treatment
  • Application
    • Diagnostic Imaging
    • Drug Delivery
    • Implants
    • Regenerative Medicine
    • Vaccines
  • Indication
    • Clinical Cardiology
    • Clinical Oncology
    • Immunology
    • Infectious Diseases
    • Neurology
    • Ophthalmology
    • Orthopedics
    • Urology
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Nanomedicine Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Nanomedicine Market?

3. What are the technology trends and regulatory frameworks in the Nanomedicine Market?

4. What is the market share of the leading vendors in the Nanomedicine Market?

5. Which modes and strategic moves are suitable for entering the Nanomedicine Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Nanomedicine Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Prevalence of chronic diseases and need for efficient treatment
      • 5.1.1.2. Utilization of nanomedicine technology for personalized medicine
      • 5.1.1.3. Applications in vitro diagnostics and in vivo imaging
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of development and commercialization of nanomedicine
    • 5.1.3. Opportunities
      • 5.1.3.1. Strategic alliances for development of novel nanomedicine
      • 5.1.3.2. Favorable funding landscape for research and development of nanomedicine
    • 5.1.4. Challenges
      • 5.1.4.1. Limited availability of clinical evidence
  • 5.2. Market Segmentation Analysis
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Nanomedicine Market, by Molecule Type

  • 6.1. Introduction
  • 6.2. Nanodevices
  • 6.3. Nanoparticles
    • 6.4.1. Dendrimers
    • 6.4.2. Hydrogel Nanoparticles
    • 6.4.3. Inorganic Nanoparticles
    • 6.4.4. Liposomes
    • 6.4.5. Metal & Metal Oxide Nanoparticles
    • 6.4.6. Polymers & Polymer Drug Conjugates
  • 6.4. Nanoshells
  • 6.5. Nanotubes

7. Nanomedicine Market, by Modality

  • 7.1. Introduction
  • 7.2. Diagnostics
  • 7.3. Treatment

8. Nanomedicine Market, by Application

  • 8.1. Introduction
  • 8.2. Diagnostic Imaging
  • 8.3. Drug Delivery
  • 8.4. Implants
  • 8.5. Regenerative Medicine
  • 8.6. Vaccines

9. Nanomedicine Market, by Indication

  • 9.1. Introduction
  • 9.2. Clinical Cardiology
  • 9.3. Clinical Oncology
  • 9.4. Immunology
  • 9.5. Infectious Diseases
  • 9.6. Neurology
  • 9.7. Ophthalmology
  • 9.8. Orthopedics
  • 9.9. Urology

10. Americas Nanomedicine Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Nanomedicine Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Nanomedicine Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. FPNV Positioning Matrix
  • 13.2. Market Share Analysis, By Key Player
  • 13.3. Competitive Scenario Analysis, By Key Player

14. Competitive Portfolio

  • 14.1. Key Company Profiles
    • 14.1.1. AMAG Pharmaceuticals, Inc.
    • 14.1.2. Amgen Inc.
    • 14.1.3. Arrowhead Pharmaceuticals, Inc.
    • 14.1.4. Bausch Health Companies Inc.
    • 14.1.5. Bayer Healthcare
    • 14.1.6. Biogen Inc.
    • 14.1.7. Bristol-Myers Squibb Company
    • 14.1.8. Celgene Corporation
    • 14.1.9. Eisai Co Ltd
    • 14.1.10. F. Hoffmann-La Roche AG
    • 14.1.11. Galen Ltd
    • 14.1.12. General Electric Company
    • 14.1.13. Gilead Sciences, Inc.
    • 14.1.14. Ipsen SA
    • 14.1.15. Jazz Pharmaceuticals plc
    • 14.1.16. Lantheus Holdings, Inc.
    • 14.1.17. Leadient BioSciences Inc.
    • 14.1.18. Mallinckrodt Pharmaceuticals
    • 14.1.19. Merck & Co., Inc.
    • 14.1.20. Nano spectra Biosciences, Inc.
    • 14.1.21. Novo Nordisk A/S
    • 14.1.22. OSARTIS GmbH
    • 14.1.23. Pacira BioSciences Inc.
    • 14.1.24. Pfizer Inc.
    • 14.1.25. Sanofi S.A.
    • 14.1.26. Taiwan Liposome Company, Ltd.
    • 14.1.27. Takeda Pharmaceutical Company Limited
    • 14.1.28. Teva Pharmaceuticals Ltd.
    • 14.1.29. UCB SA
    • 14.1.30. Zimmer Biomet Holdings, Inc.
  • 14.2. Key Product Portfolio

15. Appendix

  • 15.1. Discussion Guide
  • 15.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. NANOMEDICINE MARKET RESEARCH PROCESS
  • FIGURE 2. NANOMEDICINE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. NANOMEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. NANOMEDICINE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. NANOMEDICINE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NANOMEDICINE MARKET DYNAMICS
  • FIGURE 7. NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2030 (%)
  • FIGURE 8. NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. NANOMEDICINE MARKET SIZE, BY MODALITY, 2023 VS 2030 (%)
  • FIGURE 10. NANOMEDICINE MARKET SIZE, BY MODALITY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. NANOMEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 12. NANOMEDICINE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. NANOMEDICINE MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 14. NANOMEDICINE MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. AMERICAS NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. AMERICAS NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. UNITED STATES NANOMEDICINE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 18. UNITED STATES NANOMEDICINE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 22. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 23. NANOMEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 24. NANOMEDICINE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. NANOMEDICINE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. NANOMEDICINE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL NANOMEDICINE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. NANOMEDICINE MARKET SIZE, BY NANODEVICES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 9. NANOMEDICINE MARKET SIZE, BY DENDRIMERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. NANOMEDICINE MARKET SIZE, BY HYDROGEL NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. NANOMEDICINE MARKET SIZE, BY INORGANIC NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. NANOMEDICINE MARKET SIZE, BY LIPOSOMES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. NANOMEDICINE MARKET SIZE, BY METAL & METAL OXIDE NANOPARTICLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. NANOMEDICINE MARKET SIZE, BY POLYMERS & POLYMER DRUG CONJUGATES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. NANOMEDICINE MARKET SIZE, BY NANOSHELLS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. NANOMEDICINE MARKET SIZE, BY NANOTUBES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 18. NANOMEDICINE MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. NANOMEDICINE MARKET SIZE, BY TREATMENT, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 21. NANOMEDICINE MARKET SIZE, BY DIAGNOSTIC IMAGING, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. NANOMEDICINE MARKET SIZE, BY DRUG DELIVERY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. NANOMEDICINE MARKET SIZE, BY IMPLANTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. NANOMEDICINE MARKET SIZE, BY REGENERATIVE MEDICINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. NANOMEDICINE MARKET SIZE, BY VACCINES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 27. NANOMEDICINE MARKET SIZE, BY CLINICAL CARDIOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. NANOMEDICINE MARKET SIZE, BY CLINICAL ONCOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. NANOMEDICINE MARKET SIZE, BY IMMUNOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 30. NANOMEDICINE MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 31. NANOMEDICINE MARKET SIZE, BY NEUROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 32. NANOMEDICINE MARKET SIZE, BY OPHTHALMOLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 33. NANOMEDICINE MARKET SIZE, BY ORTHOPEDICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 34. NANOMEDICINE MARKET SIZE, BY UROLOGY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 35. AMERICAS NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. AMERICAS NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 37. AMERICAS NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 38. AMERICAS NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. AMERICAS NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 40. AMERICAS NANOMEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 41. ARGENTINA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 42. ARGENTINA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 43. ARGENTINA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 44. ARGENTINA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 46. BRAZIL NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. BRAZIL NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 48. BRAZIL NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 49. BRAZIL NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. BRAZIL NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 51. CANADA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. CANADA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 53. CANADA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 54. CANADA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 55. CANADA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 56. MEXICO NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. MEXICO NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 58. MEXICO NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 59. MEXICO NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. MEXICO NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 61. UNITED STATES NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. UNITED STATES NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 63. UNITED STATES NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 64. UNITED STATES NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. UNITED STATES NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 66. UNITED STATES NANOMEDICINE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 67. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 69. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 70. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 72. ASIA-PACIFIC NANOMEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 73. AUSTRALIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. AUSTRALIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 75. AUSTRALIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 76. AUSTRALIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. AUSTRALIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 78. CHINA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 79. CHINA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 80. CHINA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 81. CHINA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 82. CHINA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 83. INDIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. INDIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 85. INDIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 86. INDIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. INDIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 88. INDONESIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. INDONESIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 90. INDONESIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 91. INDONESIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 92. INDONESIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 93. JAPAN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. JAPAN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 95. JAPAN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 96. JAPAN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. JAPAN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 98. MALAYSIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 99. MALAYSIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 100. MALAYSIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 101. MALAYSIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 102. MALAYSIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 103. PHILIPPINES NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 104. PHILIPPINES NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 105. PHILIPPINES NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 106. PHILIPPINES NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 107. PHILIPPINES NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 108. SINGAPORE NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 109. SINGAPORE NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 110. SINGAPORE NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 111. SINGAPORE NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 112. SINGAPORE NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 113. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 115. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 116. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 117. SOUTH KOREA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 118. TAIWAN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 119. TAIWAN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 120. TAIWAN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 121. TAIWAN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 122. TAIWAN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 123. THAILAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 124. THAILAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 125. THAILAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 126. THAILAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 127. THAILAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 128. VIETNAM NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 129. VIETNAM NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 130. VIETNAM NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 131. VIETNAM NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 132. VIETNAM NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 133. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 135. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 136. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 138. EUROPE, MIDDLE EAST & AFRICA NANOMEDICINE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 139. DENMARK NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 140. DENMARK NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 141. DENMARK NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 142. DENMARK NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 143. DENMARK NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 144. EGYPT NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 145. EGYPT NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 146. EGYPT NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 147. EGYPT NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 148. EGYPT NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 149. FINLAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. FINLAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 151. FINLAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 152. FINLAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 153. FINLAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 154. FRANCE NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 155. FRANCE NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 156. FRANCE NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 157. FRANCE NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 158. FRANCE NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 159. GERMANY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 160. GERMANY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 161. GERMANY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 162. GERMANY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 163. GERMANY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 164. ISRAEL NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 165. ISRAEL NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 166. ISRAEL NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 167. ISRAEL NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 168. ISRAEL NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 169. ITALY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. ITALY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 171. ITALY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 172. ITALY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 173. ITALY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 174. NETHERLANDS NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 175. NETHERLANDS NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 176. NETHERLANDS NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 177. NETHERLANDS NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 178. NETHERLANDS NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 179. NIGERIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 180. NIGERIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 181. NIGERIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 182. NIGERIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 183. NIGERIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 184. NORWAY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 185. NORWAY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 186. NORWAY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 187. NORWAY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 188. NORWAY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 189. POLAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. POLAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 191. POLAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 192. POLAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 193. POLAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 194. QATAR NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 195. QATAR NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 196. QATAR NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 197. QATAR NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 198. QATAR NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 199. RUSSIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 200. RUSSIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 201. RUSSIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 202. RUSSIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 203. RUSSIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 204. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 205. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 206. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 207. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 208. SAUDI ARABIA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 209. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 210. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 211. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 212. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 213. SOUTH AFRICA NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 214. SPAIN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 215. SPAIN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 216. SPAIN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 217. SPAIN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 218. SPAIN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 219. SWEDEN NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 220. SWEDEN NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 221. SWEDEN NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 222. SWEDEN NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 223. SWEDEN NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 224. SWITZERLAND NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 225. SWITZERLAND NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 226. SWITZERLAND NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 227. SWITZERLAND NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 228. SWITZERLAND NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 229. TURKEY NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 230. TURKEY NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 231. TURKEY NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 232. TURKEY NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 233. TURKEY NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 238. UNITED ARAB EMIRATES NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 239. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY MOLECULE TYPE, 2018-2030 (USD MILLION)
  • TABLE 240. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY NANOPARTICLES, 2018-2030 (USD MILLION)
  • TABLE 241. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY MODALITY, 2018-2030 (USD MILLION)
  • TABLE 242. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 243. UNITED KINGDOM NANOMEDICINE MARKET SIZE, BY INDICATION, 2018-2030 (USD MILLION)
  • TABLE 244. NANOMEDICINE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 245. NANOMEDICINE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 246. NANOMEDICINE MARKET LICENSE & PRICING